Your browser doesn't support javascript.
loading
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer.
Santonja, Angela; Cooper, Wendy N; Eldridge, Matthew D; Edwards, Paul A W; Morris, James A; Edwards, Abigail R; Zhao, Hui; Heider, Katrin; Couturier, Dominique-Laurent; Vijayaraghavan, Aadhitthya; Mennea, Paulius; Ditter, Emma-Jane; Smith, Christopher G; Boursnell, Chris; Manzano García, Raquel; Rueda, Oscar M; Beddowes, Emma; Biggs, Heather; Sammut, Stephen-John; Rosenfeld, Nitzan; Caldas, Carlos; Abraham, Jean E; Gale, Davina.
Afiliação
  • Santonja A; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Cooper WN; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
  • Eldridge MD; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Edwards PAW; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
  • Morris JA; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Edwards AR; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
  • Zhao H; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Heider K; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
  • Couturier DL; Department of Pathology, University of Cambridge, Cambridge, UK.
  • Vijayaraghavan A; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Mennea P; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
  • Ditter EJ; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Smith CG; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Boursnell C; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
  • Manzano García R; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Rueda OM; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
  • Beddowes E; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Biggs H; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
  • Sammut SJ; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
  • Rosenfeld N; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Caldas C; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
  • Abraham JE; Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK.
  • Gale D; Cancer Research UK Cambridge Centre, Cancer Research UK Cambridge Institute, Li Ka Shing Centre, Cambridge, UK.
EMBO Mol Med ; 15(6): e16505, 2023 06 07.
Article em En | MEDLINE | ID: mdl-37161793

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / DNA Tumoral Circulante Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: EMBO Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / DNA Tumoral Circulante Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: EMBO Mol Med Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido